Turn Bio receives positive feedback following an FDA INTERACT meeting to advance epigenetic reprogramming for skin rejuvenation into clinical trials QUADSMaster October 25, 2023
quadraScope to present at the NYC Longevity + DeSci Summit organized by Lifespan.io QUADSMaster July 19, 2023
quadraScope’s presentation at the Foresight Institute Longevity Frontiers Workshop QUADSMaster June 30, 2023
Immunis has promising results in clinical trial and wins award for Best Immune Deficit Treatment Development QUADSMaster May 9, 2023